We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.96B
AUM Growth
+$154M
Cap. Flow
-$3.99M
Cap. Flow %
-0.2%
Top 10 Hldgs %
39.58%
Holding
252
New
17
Increased
77
Reduced
80
Closed
15

Top Buys

Rank Stock Value
1
EA icon
Electronic Arts
EA
+$13.2M
2
GRMN
Garmin
GRMN
+$10.1M
3
XOM icon
ExxonMobil
XOM
+$8.12M
4
GPN icon
Global Payments
GPN
+$7.78M
5
CTSH icon
Cognizant
CTSH
+$6.95M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$15.4M
2
IBM icon
IBM
IBM
+$13.3M
3
TFC icon
Truist Financial
TFC
+$10.6M
4
CVX icon
Chevron
CVX
+$9.75M
5
LOW icon
Lowe's Companies
LOW
+$9.67M

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.86%
2 Technology 22.18%
3 Healthcare 11.79%
4 Financials 11.08%
5 Consumer Discretionary 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXP icon
26
American Express
AXP
$228B
$18.4M 0.94%
112,545
+3,628
+3% +$619K
INTU icon
27
Intuit
INTU
$86.3B
$18.2M 0.93%
28,318
-1,377
-5% -$850K
VZ icon
28
Verizon
VZ
$193B
$17.7M 0.9%
339,751
+63,998
+23% +$3.34M
CVS icon
29
CVS Health
CVS
$134B
$17.5M 0.89%
169,769
+16,488
+11% +$1.52M
BMY icon
30
Bristol-Myers Squibb
BMY
$132B
$17.3M 0.88%
277,232
+2,200
+0.8% +$129K
ABBV icon
31
AbbVie
ABBV
$455B
$17.3M 0.88%
127,443
+36,841
+41% +$4.35M
ABT icon
32
Abbott
ABT
$183B
$17.1M 0.87%
121,299
+19,807
+20% +$2.54M
ORCL icon
33
Oracle
ORCL
$367B
$16.7M 0.85%
191,120
+1,930
+1% +$181K
INTC icon
34
Intel
INTC
$460B
$16.6M 0.84%
321,701
+3,153
+1% +$161K
PSA icon
35
Public Storage
PSA
$59.3B
$16M 0.81%
42,700
UPS icon
36
United Parcel Service
UPS
$89.5B
$15.9M 0.81%
74,308
+1,167
+2% +$237K
CCI icon
37
Crown Castle
CCI
$33.4B
$14.9M 0.76%
71,267
+6,082
+9% +$1.12M
SPY icon
38
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$14.8M 0.75%
31,213
-425
-1% -$195K
AFL icon
39
Aflac
AFL
$64.8B
$14.8M 0.75%
253,518
+79,468
+46% +$4.45M
TJX icon
40
TJX Companies
TJX
$176B
$14.8M 0.75%
194,585
+6,565
+3% +$455K
UNH icon
41
UnitedHealth
UNH
$383B
$14.3M 0.73%
28,445
-2,777
-9% -$1.26M
RTX icon
42
RTX Corp
RTX
$289B
$13.6M 0.69%
158,577
+500
+0.3% +$43.6K
USB icon
43
US Bancorp
USB
$98B
$13.1M 0.67%
233,575
+15,735
+7% +$931K
YUM icon
44
Yum! Brands
YUM
$43.3B
$12.8M 0.65%
92,074
+49,404
+116% +$6.32M
DE icon
45
Deere & Co
DE
$162B
$12.5M 0.64%
36,545
-931
-2% -$324K
DUK icon
46
Duke Energy
DUK
$98.4B
$12.5M 0.64%
119,151
+2,461
+2% +$249K
TFC icon
47
Truist Financial
TFC
$63.5B
$12.5M 0.64%
213,184
-172,895
-45% -$10.6M
MDT icon
48
Medtronic
MDT
$110B
$11.7M 0.6%
113,202
+1,186
+1% +$137K
PYPL icon
49
PayPal
PYPL
$49.3B
$10.8M 0.55%
57,237
+8,500
+17% +$1.84M
CTVA icon
50
Corteva
CTVA
$59.8B
$10.6M 0.54%
224,645
+19,747
+10% +$899K

Similar funds

Cullinan Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Cullinan Associates held 252 positions worth $1.96B, up 8.5% from $1.81B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cullinan Associates's Q4 2021 filing shows 17 new, 77 increased, 80 reduced and 15 closed positions. Its largest new stake was Garmin: 69,916 shares worth $9.52M. The largest sale was Accenture, an estimated $15.4M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 24% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q4 2021 buy was Garmin: 69,916 shares worth $9.52M.
  • Cullinan Associates added most to Electronic Arts in Q4 2021, an estimated $13.2M increase.
  • Cullinan Associates's biggest Q4 2021 reduction was Accenture, cutting an estimated $15.4M.
  • Cullinan Associates fully exited Schrodinger in Q4 2021, selling an estimated $2.88M.
  • Cullinan Associates's ten largest holdings make up 40% of its $1.96B portfolio in Q4 2021.
  • Cullinan Associates opened 17 new positions and closed 15 in Q4 2021.
  • Cullinan Associates's portfolio value rose 8.5% quarter-over-quarter to $1.96B.

Based on Cullinan Associates's 13F filing for Q4 2021, filed 7 Jan 2022.